*001558736
*00520250613174355.0
*007ta
*008140709s2002    xxu           000 u eng d
*00901940cam a2200457 c 4500
*019  $bl
*020  $a0824707877
*035  $a(EXLNZ-47BIBSYS_NETWORK)990303835014702201
*035  $a(NO-LaBS)14119641(bibid)
*035  $a(NO-TrBIB)030383501
*035  $a(SIHF)0000001195
*035  $a030383501-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*060 4$aWP
*060 4$aWP 870
*06014$aWP
*24500$aEndocrine therapy in breast cancer$cedited by William R. Miller, James N. Ingle
*260  $aNew York$bMarcel Dekker$cc2002
*300  $aXIV, 378 s.$bill.
*650 0$aBreast$xCancer Endocrine aspects$_84898300
*650 0$aSelective estrogen receptor modulators$_84898400
*650 0$aTamoxifen$_38048200
*650 2$aAntineoplastic Agents$_10522400
*650 2$aAntineoplastic Agents, Hormonal$xtherapeutic use$_84898500
*650 2$aBreast Neoplasms$_10032400
*650 2$aBreast Neoplasms$xprevention & control$_26313100
*650 2$aBreast neoplasms$xDrug therapy$_16692100
*650 2$aChemotherapy, Adjuvant$_27844200
*650 2$aChemotherapy, Adjuvant$xmethods$_84898600
*7001 $aIngle, James N.$0(NO-TrBIB)3034930$_84898700
*7001 $aMiller, William R.$d1944-$0(NO-TrBIB)9067114$_84898800
*7760 $tEndocrine therapy in breast cancer$w990519590894702201
*85642$3Forlagets beskrivelse (kort)$uhttps://contents.bibs.aws.unit.no/?isbn=0824707877
*85642$3Forlagets beskrivelse (kort)$uhttps://contents.bibs.aws.unit.no/content/?isbn=9780824707873
*85642$3Forlagets beskrivelse (lang)$uhttps://contents.bibs.aws.unit.no/?isbn=0824707877
*85642$3Forlagets beskrivelse (lang)$uhttps://contents.bibs.aws.unit.no/content/?isbn=9780824707873
*85642$3Innholdsfortegnelse$uhttps://contents.bibs.aws.unit.no/?isbn=0824707877
*85642$3Innholdsfortegnelse$uhttps://contents.bibs.aws.unit.no/content/?isbn=9780824707873
*85642$3Omslagsbilde$uhttps://contents.bibs.aws.unit.no/files/images/large/3/7/9780824707873.jpg$qimage/jpeg
*901  $a80
*999  $aoai:nb.bibsys.no:990303835014702202$b2021-11-14T20:30:47Z$z990303835014702202
^